Selective digestive decontamination reduces mortality among intensive care patients;Selectieve darmdecontaminatie voorkomt sterfte bij intensive- carepatienten

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 12, 1999, Pages 602-605

  Rommes, J H ^a   Zandstra, D F ^b   Van Saene, H K F ^c  

^a Ziekenhuiscentrum Apeldoorn   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFOTAXIME; COLISTIN; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CRITICAL ILLNESS; HOSPITAL INFECTION; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE; MORTALITY; SHORT SURVEY;

EID: 0033586373     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (49)

1. Stoutenbeek CP, Saene HKF van, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 1984;10:185-92.
2. Waaij D van der, Sluiter HJ. Luchtweginfecties bij patiënten in afdelingen voor intensieve behandeling; pathogenese en preventie. Ned Tijdschr Geneeskd 1986;130:854-8.
3. Dalen R van, Meer JWM van der. Klinisch belang van selectieve decontaminatie bij patienten op de intensive care-afdeling. Ned Tijdschr Geneeskd 1990;134:1165-8.
4. Bonten MJM, Stobberingh EE, Geest S van der, Tiel FH van, Gaillard CA. Selectieve decontaminatie van de tractus digestivus bij beademde patiënten op een intensive care-afdeling: meer argumenten contra dan pro. Ned Tijdschr Geneeskd 1994;138:1606-12.
5. Meer JWM van der, Kullberg BJ. Infecties tijdens intensive care: een vicieuze cirkel. Ned Tijdschr Geneeskd 1994;138:2229-31.
6. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316: 1275-85.
7. Baxby D, Saene HKF van, Stoutenbeek CP, Zandstra DF. Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Intensive Care Med 1996;22:699-706.
8. Mandelli M, Mosconi P, Langer M, Cigada M. Is pneumonia developing in patients in intensive care always a typical 'nosocomial' infection [letter]? Lancet 1986;ii:1094-5.
9. Murray AE, Chambers JJ, Saene HKF van. Infections in patients requiring ventilation in intensive care: application of a new classification. Clin Microbiol Infect 1998;4:94-102.
10. Morar P, Singh V, Jones AS, Hughes J, Saene R van. Impact of tracheotomy on colonization and infection of lower airways in children requiring long-term ventilation: a prospective observational cohort study. Chest 1998;113:77-85.
11. Vandenbroucke-Grauls CMJE, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991; 338:859-62.
12. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993;307: 525-32.
13. Heyland DK, Cook DJ, Jaeschke R, Griffith L, Lee HN, Guyatt GH. Selective decontamination of the digestive tract. An overview. Chest 1994;105:1221-9.
14. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest 1994;105:1101-8.
15. Hurley JC. Prophylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection? Antimicrob Agents Chemother 1995;39:941-7.
16. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med 1992;326:594-9.
17. Hammond JMJ, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992;340:5-9.
18. Ferrer M, Torres A, Gonzalez J, Puig de la Bellacasa J, el-Ebiary M, Roca M, et al. Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 1994;120:389-95.
19. Wiener J, Itokazu G, Nathan C, Kabins SA, Weinstein RA. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis 1995;20:861-7.
20. Verwaest C, Verhaegen J, Ferdinande P, Schetz M, Berghe G van den, Verbist L, et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997;25:63-71.
21. Lingnau W, Berger J, Javorsky F, Lejeune P, Mutz N, Benzer H. Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 1997;42:687-94.
22. Saene JJM van, Stoutenbeek CP, Saene HKF van, Matera G, Martinez-Pellus AE, Ramsay G. Reduction of the intestinal endotoxin pool by three different SDD regimens in human volunteers. J Endotoxin Res 1996;3:337-43.
23. Mason CM, Dobard E, Summer WR, Nelson S. Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J Infect Dis 1997;176:1293-302.
24. Yao YM, Lu LR, Yu Y, Liang HP, Chen JS, Shi ZG, et al. Influence of selective decontamination of the digestive tract on cell-mediated immune function and bacteria/endotoxin translocation in thermally injured rats. J Trauma 1997;42:1073-9.
25. Tetteroo GWM, Wagenvoort JHT, Mulder PGH, Ince C, Bruining HA. Decreased mortality and length of stay in surgical intensive care patients with successful selective decontamination of the gut. Crit Care Med 1993;21:1692-8.
26. Smith CR. Cefotaxime and cephalosporins: adverse reactions in perspective. Rev Infect Dis 1982;4 Suppl:S481-8.
27. Saene HKF van, Damjanovic V, Murray AE, De la Cal MA. How to classify infections in intensive care units - the carrier state, a criterion whose time has come? J Hosp Infect 1996;33:1-12.
28. Hammond JM, Potgieter PD. Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 1995;23:637-45.
29. Stoutenbeek CP, Saene HKF van, Zandstra DF. The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 1987; 19:513-20.
30. Tetteroo GWM, Wagenvoort JHT, Bruining HA. Bacteriology of selective decontamination: efficacy and rebound colonization. J Antimicrob Chemother 1994;34:139-48.
31. Saunders GL, Hammond JMJ, Potgieter PD, Plumb HA, Forder AA. Microbiological surveillance during selective decontamination of the digestive tract (SDD). J Antimicrob Chemother 1994;34:529-44.
32. Modi N, Damjanovic V, Cooke RWI. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child 1987;62:148-51.
33. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, et al. Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 1989;110:873-81.
34. Taylor ME, Oppenheim BA. Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991;17:271-8.
35. Brun-Buisson C, Saene HKF van. SDD and the novel extended-broad-spectrum beta-lactamases [letter]. J Antimicrob Chemother 1991;28:145-7.
36. Lucet JC, Chevret S, Decré D, Vanjak D, Macrez A, Bedos JP, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430-6.
37. Hilgeman CN, Koopmanschap MA, Rutten FFH. Kosten van intensieve zorg in Nederland. Ned Tijdschr Geneeskd 1994;138:2252-6.
38. Jacobs P, Noseworthy TW. National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 1990;18:1282-6.
39. Saene HKF van, Fox MA, Stoutenbeek CP. Treating selective decontamination of the digestive tract vs cost-effectiveness analysis [letter]. Chest 1995;108:288.
40. Rocha LA, Martin MJ, Pita S, Paz J, Seco C, Margusino L, et al. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study. Intensive Care Med 1992;18:398-404.
41. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 1993;21:1466-73.
42. Stoutenbeek CP, Saene HKF van, Zandstra DF. Prevention of multiple organ system failure by selective decontamination of the digestive tract in multiple trauma patients. In: Faist E, Baue AE, Schildberg FW, editors. The immune consequences of trauma, shock and sepsis. Lengerich: Pabst Sciences Publishers; 1996. p. 1055-66.
43. Sanchez Garcia M, Cambronero Galache JA, Lopez Dias J, Cerda Cerda E, Rubio Blasco J, Gomez Aguinaga MA, et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 1998; 158:908-16.
44. Bonten MJM, Weinstein RA. Selective decontamination of the digestive tract: a measure whose time has passed? Curr Opin Infect Dis 1996;9:270-5.
45. Spencer RC. Infections in patients requiring ventilation in intensive care: a critique of the application of a new classification. Clin Microbiol Infect 1998;4:100-2.
46. Kullberg BJ, Meer JWM van der. Infectieziekten. In: Es JC van, Keeman JN, Leeuw PJ de, Verstraete M, redacteuren. Het medisch jaar 1997. Houten: Bohn Stafleu Van Loghum: 1997. p. 248-61.
47. Saene HKF van, Damjanovic V, Williets T, Mostafa SM, Fox MA, Petros AJ. Pathogenesis of ventilator-associated pneumonia: is the contribution of biofilm clinically significant [letter]? J Hosp Infect 1998;38:231-5.
48. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence based medicine. How to practice and teach EBM. New York: Churchill Livingstone; 1997.
49. Chalmers I. Human albumin administration in critically ill patients. I would not want an albumin transfusion [letter]. BMJ 1998;317:885.